SCHEMBL15426497

SCHEMBL15426497

Cc1ccc2c(c1)nc(-c1ccc(C(F)(F)F)cc1F)n2C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.49
PIK3CA P42336 1/20 0.46
PIK3CB P42338 1/20 0.46
PIK3CG P48736 1/20 0.46
PDE2A O00408 3/20 0.45
PDE10A Q9Y233 2/20 0.45
AGPAT2 O15120 2/20 0.43
ACSS2 Q9NR19 1/20 0.43
MPL P40238 1/20 0.40
KDM4E B2RXH2 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MCHR1 Q99705 2/20 0.37
GRM2 Q14416 1/20 0.37
PTGDR2 Q9Y5Y4 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
TYK2 P29597 1/20 0.36
JAK3 P52333 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10281012 0.93 HSD11B1 (0.52) HSD11B1PIK3CAPIK3CBPIK3CGPDE2A
SCHEMBL15426449 0.81 PIK3CA (0.42) PIK3CAPIK3CBPIK3CGPDE2APDE10A
SCHEMBL15426450 0.80 DDR1 (0.44) PIK3CAPIK3CBPIK3CGPDE2AAGPAT2
SCHEMBL167106 0.80 PDE10A (0.46) HSD11B1PIK3CAPIK3CBPIK3CGPDE2A
SCHEMBL15426486 0.80 HSD11B1 (0.47) HSD11B1PDE2APDE10AMPLMCHR1
SCHEMBL15426448 0.79 PIK3CA (0.41) PIK3CAPIK3CBPIK3CGAGPAT2ACSS2
SCHEMBL15426505 0.79 HSD11B1 (0.46) HSD11B1PDE2APDE10AMPLGRM2
SCHEMBL355769 0.78 PDE2A (0.44) HSD11B1PIK3CAPIK3CBPIK3CGPDE2A
SCHEMBL24397667 0.77 PDE2A (0.46) HSD11B1PIK3CAPIK3CBPIK3CGPDE2A
SCHEMBL29497618 0.77 PDE2A (0.46) HSD11B1PIK3CAPIK3CBPIK3CGPDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278983-B2 Fused heterocyclic compound and use thereof for pest control SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-03-08 US disclosed
US-20140364444-A1 FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-12-11 US disclosed
US-8853238-B2 Fused heterocyclic compound and use thereof for pest control SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-10-07 US disclosed
US-20140018373-A1 FUSED HETEROCYCLIC COMPOUND AND USE FOR PEST CONTROL THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140018373-A1 FUSED HETEROCYCLIC COMPOUND AND USE FOR PEST CONTROL THEREOF NR4A1, NR2C2, NR0B1 HSD11B1 1704/4885PIK3CA 4291/4885PIK3CB 4032/4885
US-20140364444-A1 FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL NR4A1, NR2C2, NR0B1 HSD11B1 1639/4885PIK3CA 4183/4885PIK3CB 3934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.